Hennion & Walsh Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Hennion & Walsh Asset Management's ELV Position: Q2 2025 in Review
Hennion & Walsh Asset Management sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 1,265 shares — an estimated $550K sold.
Hennion & Walsh Asset Management first reported a position in ELV in Q1 2021 and held it in 17 quarters. The position peaked at $7.84M in Q4 2022. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.
- Hennion & Walsh Asset Management reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
- Hennion & Walsh Asset Management sold 1,265 Elevance Health shares in Q2 2025, an estimated $550K.
- Hennion & Walsh Asset Management first reported a position in Elevance Health in Q1 2021 and held it in 17 quarters.
- Hennion & Walsh Asset Management's Elevance Health position peaked at $7.84M in Q4 2022.
- 1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.
Based on Hennion & Walsh Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.